source
- STAT+: Hims’ sales miss as telehealth competition growsBristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The ReadoutSTAT · 3mo ago↗ source
- Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugA deal with Rigel Pharmaceuticals ends months of uncertainty about the future of Veppanu, a first-of-its-kind, newly approved medicine with a murky financial outlook.BioPharma Dive · 3mo ago↗ source
- Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotechIsomorphic Labs said Tuesday it had closed a $2.1 billion Series B round, cementing its bellwether role in using AI for drug discovery. For privately held companies, Isomorphic’s raise is the secon…Endpoints · 3mo ago